Ensuring Patient Access And Effective Drug Enforcement Act
   HOME

TheInfoList



OR:

The Ensuring Patient Access and Effective Drug Enforcement Act of 2016 is a United States
federal statute In the law of the United States, the Code of Laws of the United States of America (variously abbreviated to Code of Laws of the United States, United States Code, U.S. Code, U.S.C., or USC) is the official compilation and codification of the ...
enacted by the
114th United States Congress The 114th United States Congress was a meeting of the legislative branch of the United States of America federal government, composed of the United States Senate and the United States House of Representatives. It met in Washington, D.C. from Jan ...
and signed into law by
President Barack Obama Barack Hussein Obama II ( ; born August 4, 1961) is an American politician who served as the 44th president of the United States from 2009 to 2017. A member of the Democratic Party (United States), Democratic Party, Obama was the first Af ...
on April 19, 2016. It modified the
Controlled Substances Act The Controlled Substances Act (CSA) is the statute establishing federal government of the United States, federal drug policy of the United States, U.S. drug policy under which the manufacture, importation, possession, use, and distribution of ...
, which requires the
Drug Enforcement Administration The Drug Enforcement Administration (DEA; ) is a Federal law enforcement in the United States, United States federal law enforcement agency under the U.S. Department of Justice tasked with combating drug trafficking and distribution within th ...
(DEA) to identify "imminent danger to the public health and safety" before suspending the registration of a manufacturer, distributor, or dispenser for controlled substances privileges. It "hampered the DEA's ability to seize suspicious shipments f opioids within the context of the
opioid epidemic The opioid epidemic, also referred to as the opioid crisis, is the rapid increase in the overuse, misuse/abuse, and overdose deaths attributed either in part or in whole to the class of drugs opiates/opioids since the 1990s. It includes the sign ...
. It was cosponsored by Sen.
Sheldon Whitehouse Sheldon Whitehouse (born October 20, 1955) is an American lawyer and politician serving as the junior United States senator from Rhode Island since 2007. A member of the Democratic Party, he served as a United States Attorney from 1993 to 1998 ...
-RI Sen.
Marco Rubio Marco Antonio Rubio (born May 28, 1971) is an American politician and lawyer serving as the senior United States senator from Florida, a seat he has held since 2011. A member of the Republican Party, he served as Speaker of the Florida Hous ...
-FL Sen.
David Vitter David Bruce Vitter (born May 3, 1961) is an American lobbyist, lawyer, and politician who served as United States Senator for Louisiana from 2005 to 2017. A Republican, Vitter served in the Louisiana House of Representatives from 1992 to 1999. ...
-LA Rep.
Marsha Blackburn Mary Marsha Blackburn (née Wedgeworth; born June 6, 1952) is an American politician and businesswoman serving as the senior United States Senate, United States senator from Tennessee, a seat she has held since 2019. She is a member of the Repu ...
and Sen.
Bill Cassidy William Morgan Cassidy (born September 28, 1957) is an American physician and politician serving as the senior United States senator from Louisiana, a seat he has held since 2015. A member of the Republican Party, he served in the Louisian ...
-LA An earlier iteration of the bill was introduced by Rep.
Tom Marino Thomas Anthony Marino (born August 13, 1952) is an American politician and attorney, who served as a United States Representative from Pennsylvania from 2011 to 2019. He represented the from January 3, 2011 to January 3, 2019, and the from Janu ...
-PAand passed the House of Representatives in 2015. This was purportedly the reason behind Marino's withdrawal of his candidacy for Director of the
Office of National Drug Control Policy The Office of National Drug Control Policy (ONDCP) is a component of the Executive Office of the President of the United States. The Director of the ONDCP, colloquially known as the Drug Czar, heads the office. "Drug Czar" was a term first used ...
(aka
drug czar Drug czar is an informal name for the person who directs drug-control policies in various areas. The term follows the informal use of the term ''czar'' in U.S. politics. The 'drug czar' title first appeared in a 1982 news story by United Press Int ...
). It has been reported on by various news agencies including the Washington Post, Fox News, USA Today, and the story was originally broken by CBS/60 Minutes.


References

Acts of the 114th United States Congress United States federal controlled substances legislation Drug Enforcement Administration United States domestic policy Public policy of the Obama administration Controlled Substances Act {{US-federal-legislation-stub